A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop.
通过细胞重编程和获得 FGF2-FGFR1 自分泌生长环介导的吉非替尼耐药机制
期刊:Oncogenesis
影响因子:6.4
doi:10.1038/oncsis.2013.4
Ware K E, Hinz T K, Kleczko E, Singleton K R, Marek L A, Helfrich B A, Cummings C T, Graham D K, Astling D, Tan A-C, Heasley L E